A future of AI-driven personalized care for people with multiple sclerosis

Jahr

2024

Autoren

Praet J, Anderhalten L, Comi G, Horakova D, Ziemssen T, Vermersch P, Lukas C, van Leemput K, Steppe M, Aguilera C, Kadas EM, Bertrand A, van Rampelbergh J, de Boer E, Zingler V, Smeets D, Ribbens A, Paul F.

Verlag

Front. Immunol. 2024. 15:1446748.

Link

https://doi.org/10.3389/fimmu.2024.1446748

A future of AI-driven personalized care for people with multiple sclerosis

A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network

Serum neurofilament light chain as a sensitive biomarker for neuromonitoring during extracorporeal membrane oxygenation

Raman Spectroscopy of Optically Trapped Living Human T Cell Subsets and Monocytes

COVID-19 and multiple sclerosis: challenges and lessons for patient care

Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374